Nasdaq

Dr. Reddy's Announces Launch Of OTC Diclofenac Sodium Topical Gel 1%

(RTTNews) - Dr. Reddy's Laboratories Ltd. (DRREDDY, RDY), on Wednesday, announced the launch of over-the-counter or OTC Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren Arthritis ...
Nasdaq

Dr. Reddy's Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
Monthly Prescribing Reference

Diclofenac Sodium 1% Gel Minimizes Drug-Drug Interaction-Related Adverse Events

HONOLULU, HI—Minimal systemic distribution of topical diclofenac sodium gel resulted in a lower incidence of major or moderate drug-drug interactions associated with oral diclofenac and reduced the ...
The New Indian Express

Cipla receives final approval for Diclofenac Sodium topical gel

MUMBAI: Pharma Major, Cipla said that it has received final approval on August 3, 2018, for its Abbreviated New Drug Application (ANDA) for Diclofenac Sodium Topical Gel, 1 percent from the United ...
Monthly Prescribing Reference

Perrigo Gets FDA Approval for Over-the-Counter Diclofenac Topical Gel

Perrigo announced that the FDA has approved the abbreviated New Drug Application for its over-the-counter diclofenac sodium topical gel 1% for the temporary relief of arthritis pain in the hand, wrist ...
Business Wire

Amneal & PL Developments Launch Store Brand Program of Over-the-Counter (“OTC”) Diclofenac Sodium Topical Gel, 1%

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal’ or the “Company”) and PL Developments (PLD) today announced that they have commenced shipments of store brand ...
India Infoline

Alembic Pharmaceuticals receives USFDA approval for Diclofenac Sodium Topical Gel 3Percentage

Alembic Pharmaceuticals today announced that its wholly owned subsidiary Aleor Dermaceuticals has received final approval from the US Food Drug Administration USFDA for its Abbreviated New Drug ...
The Financial Express

Aleor Dermaceuticals Limited receives USFDA final approval for Diclofenac Sodium Topical Gel

Diclofenac Sodium Topical Gel, 3% is indicated for the topical treatment of actinic keratoses. (File) Alembic Pharmaceuticals Limited (Alembic) on Friday announced that its wholly owned subsidiary, ...
The Globe and Mail

Amneal & PL Developments Launch Store Brand Program of Over-the-Counter (“OTC”) Diclofenac Sodium Topical Gel, 1%

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal’ or the “Company”) and PL Developments (PLD) today announced that they have commenced shipments of store brand equivalent Voltaren® Arthritis Pain ...